Lotus Pharmaceutical Co Ltd

Common Name
Lotus Pharmaceutical
Country
Taiwan
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
N/A
Ticker
1795
Exchange
TAIWAN STOCK EXCHANGE
Description
Lotus Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the development, manufacture, and sale of a wide range of healthcare products. Its primary function is to produce generic and spec...

Lotus Pharmaceutical's GHG Emissions Data Preview

In 2024, Lotus Pharmaceutical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Lotus Pharmaceutical has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Download Lotus Pharmaceutical's GHG Emissions data for free

Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.

Verified Sources Behind Lotus Pharmaceutical’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Lotus Pharmaceutical’s data sources below and access millions more through our Disclosure Search.

a. Lotus Pharmaceutical's Sustainability Report 2024
Trace every data point back to Lotus Pharmaceutical’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Insights into Lotus Pharmaceutical's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Lotus Pharmaceutical amounted to 15,515.044 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Lotus Pharmaceutical increased by 0.49%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

Lotus Pharmaceutical's Scope 1 Emissions Over Time

20222023202403 k6 k9 k12 ktCO2e-69%-19%
  • Total Scope 1
  • Year-over-Year Change

What are Lotus Pharmaceutical's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Lotus Pharmaceutical were 2,672.054 metric tons of CO₂ equivalent (tCO₂e). a

Has Lotus Pharmaceutical reduced its Scope 1 emissions over time?

Since 2022, Lotus Pharmaceutical's Scope 1 emissions have decreased by 74.94%, reflecting a declining long-term trend in Scope 1 emissions over time. a

Compared to the previous year (2023), Lotus Pharmaceutical's Scope 1 emissions decreased by 19.28%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a

What are Lotus Pharmaceutical's Scope 2 emissions?

In 2024, Lotus Pharmaceutical reported Scope 2 greenhouse gas (GHG) emissions of 12,842.99 tCO₂e without specifying the calculation method. a

Has Lotus Pharmaceutical reduced its Scope 2 emissions over time?

Since 2022, Lotus Pharmaceutical's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 20.63%, reflecting a rising long-term trend in Scope 2 emissions over time. a

Compared to the previous year (2023), Lotus Pharmaceutical's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Lotus Pharmaceutical 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does Lotus Pharmaceutical use for Scope 2 reporting?

In 2024, Lotus Pharmaceutical reported its Scope 2 emissions using an unspecified methodology. a

Lotus Pharmaceutical's Scope 2 Emissions Over Time

20222023202403.5 k7 k10.5 k14 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)
Want Full Access to Lotus Pharmaceutical's GHG Emissions Dataset?
Sign Up